Nautilus biotechnology, inc.NAUT.US Overview

US StockHealthcare

(No presentation for NAUT)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock Sentimental Institutions TradingView Chart

NAUT Overall Performance

NAUT AI Analysis & Strategy

NAUT Recent Performance

0.26%

Nautilus biotechnology, inc.

0.81%

Avg of Sector

-1.14%

S&P500

NAUT PowerScanner

NAUT Key Information

NAUT Valuation Metrics

NAUT Earnings Table

NAUT Profile

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was founded in 2016 and is headquartered in Seattle, Washington.